Amyloid beta peptides and type-2 diabetes sequelae synergistically inhibit insulin signaling and trafficking at the blood brain barrier
|Effective start/end date||3/1/22 → 2/28/27|
- NIH NAT INST OF NEURO DISORDERS & STROKE
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.